Scribe Therapeutics Inc. Common Stock Dividends
The next dividend date for Scribe Therapeutics Inc. Common Stock has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Scribe Therapeutics Inc. Common Stock (SCTX)
| No results. | ||||
More About Scribe Therapeutics Inc. Common Stock
Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on cardiometabolic conditions in the United States. The company offers STX-1150 designed to be a single-course in vivo epigenetic silencing treatment targeting the PCSK9 gene; STX-1200 is CRISPR-based gene editing program that aims to offer a permanent solution for patients with elevated Lp(a); and STX-1400 is designed to target and remove the transcriptional start site of the APOC3 gene and strongly reduce mRNA expression. It uses CRISPR-based platforms, such as ELXR, designed for precise, durable epigenetic silencing of genes without changing the underlying DNA sequence; and XE, designed to support specific and efficient gene editing. The company was incorporated in 2017 and is headquartered in Alameda, California.
Owning Scribe Therapeutics Inc. Common Stock Stock on the Dividend Date
If you own Scribe Therapeutics Inc. Common Stock stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Scribe Therapeutics Inc. Common Stock stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Scribe Therapeutics Inc. Common Stock stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Scribe Therapeutics Inc. Common Stock stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Scribe Therapeutics Inc. Common Stock dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Scribe Therapeutics Inc. Common Stock Dividends
You can contact us any time if you would like to ask questions about Scribe Therapeutics Inc. Common Stock dividends or anything else related to the stock market.